NIH Announces New Program to Develop Therapeutics for Rare and Neglected Diseases
May 21st, 2009 | National Institutes of Health
The National Institutes of Health (NIH) is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
Leave a Comment